83 results found.

Chronic Obstructive Pulmonary Disease Clinical Trial using Inspiratory muscle training

University Hospital, Brest - Recruiting 18 years or older.
- Effects of Inspiratory Muscle Training (IMT) on Dyspnea in COPD During Pulmonary Rehabilitation: Randomized Controlled Trial.
Inspiratory muscle training

Chronic Obstructive Pulmonary Disease, Cardiovascular Disease, or Clinical Trial

Lund University - Recruiting 35 years to 80 years.
- Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) and Cardiovascular Diseases in Smokers/Ex-Smokers Attending Primary Care - Longitudinal Study.

Pulmonary Disease, Chronic Obstructive Clinical Trial using placebo; ipratropium bromide

Boehringer Ingelheim - Recruiting 50 years to 75 years.
- Peri-operative Intervention With Nebulized Ipratropium Bromide in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial..
placebo; ipratropium bromide

Pulmonary Disease, Chronic Obstructive Clinical Trial using tiotropium; placebo; olodaterol

Boehringer Ingelheim - Recruiting 40 years or older.
- A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
tiotropium; placebo; olodaterol

Pulmonary Disease, Chronic Obstructive Clinical Trial using olodaterol; tiotropium; placebo

Boehringer Ingelheim - Recruiting 40 years or older.
- A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium+ Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
olodaterol; tiotropium; placebo

Pulmonary Disease, Chronic Obstructive Clinical Trial using olodaterol; tiotropium; Placebo

Boehringer Ingelheim - Recruiting 40 years or older.
- A Randomised, Placebo-controlled, Double-blind, Single Dose, Cross-over Study to Evaluate the Efficacy and Safety of Orally Inhaled Tiotropium + Olodaterol as Both a Fixed Dose Combination and a Free Combination (Both Delivered by the Respimatr Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD).
olodaterol; tiotropium; Placebo

Pulmonary Disease, Chronic Obstructive Clinical Trial using Placebo to BI 113608 high dose b.i.d.; Placebo to BI 113608 low dose b.i.d.; BI 113608 high dose b.i.d.; Placebo to BI 113608 medium dose b.i.d.; BI 113608 low dose b.i.d.; BI 113608 medium dose b.i.d.

Boehringer Ingelheim - Recruiting 40 years to 80 years.
- Randomized, Placebo-controlled, Double-blind Within Dose Groups, Multiple Rising-dose Study to Evaluate Safety, Tolerability, and PK of Oral BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With COPD Associated With Chronic Bronchitis.
Placebo to BI 113608 high dose b.i.d.; Placebo to BI 113608 low dose b.i.d.; BI 113608 high dose b.i.d.; Placebo to BI 113608 medium dose b.i.d.; BI 113608 low dose b.i.d.; BI 113608 medium dose b.i.d.

Pulmonary Disease, Chronic Obstructive Clinical Trial using Tiotropium Bromide 2.5 æg; Indacterol 300 æg; Tiotropium Bromide 18 æg; Indacterol 150 æg

Boehringer Ingelheim - Recruiting 40 years or older.
- Post-Marketing Observational Study of the Impact of Adherence to Treatment With Once-Daily Administered Long-Acting Bronchodilators (LABAs / LAMAs) on Patients Health Related Quality of Life in COPD Patients.
Tiotropium Bromide 2.5 æg; Indacterol 300 æg; Tiotropium Bromide 18 æg; Indacterol 150 æg

Pulmonary Disease, Chronic Obstructive Clinical Trial using Group1:Spirivar Respimatr; Group2:Hirobrizr/Oslifr/Onbrezr Breezhalerr

Boehringer Ingelheim - Recruiting 18 years or older.
- Cross-sectional Study to Assess the Handling , Patient Satisfaction, and Preference for Inhalation Devices in Patients With Chronic Obstructive Pulmonary Disease (COPD)..
Group1:Spirivar Respimatr; Group2:Hirobrizr/Oslifr/Onbrezr Breezhalerr

Pulmonary Disease, Chronic Obstructive Clinical Trial using fluticasone propionate; salmeterol; placebo; tiotropium; olodaterol

Boehringer Ingelheim - Recruiting 40 years or older.
- Randomized, Double-blind, Double-dummy, Active-controlled, 4 Period Complete Cross-over Study to Compare the Effect on Lung Function of 6 Weeks Once Daily Treatment With Orally Inhaled Tiotropium+Olodaterol Fixed Dose Combination Delivered by the Respimatr Inhaler vs. 6 Weeks Twice Daily Treatment With Fluticasone Propionate+Salmeterol Fixed Dose Combination Delivered by the Accuhalerr in Patients With Chronic Obstructive Pulmonary Disease (COPD).
fluticasone propionate; salmeterol; placebo; tiotropium; olodaterol

Chronic Obstructive Pulmonary Disease (COPD) With Cachexia Clinical Trial using Placebo; BYM338

Novartis - Recruiting 40 years to 80 years.
- A Randomized, Double Blind, Placebo Controlled, Multi-centre Study to Asses the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of BYM338 in Chronic Obstructive Pulmonary Disease Patients With Cachexia.
Placebo; BYM338

COPD Clinical Trial using Ergometer Training; Motivation

Institut fr Pneumologie Hagen Ambrock eV - Recruiting 18 years to 80 years.
- German: Effekte Eines Telemonitorisch berwachten Ergometertrainings Bei Patienten Mit Einer COPD Nach Exazerbation: Eine Prospektiv Randomisierte Studie.
Ergometer Training; Motivation

COPD Clinical Trial using Hydrolyzed casein protein; Hydrolyzed casein protein + carbohydrates; Hydrolyzed casein protein + leucine; Hydrolyzed casein protein + carbohydrates + leucine

Texas A&M University - Recruiting 45 years or older.
- Casein Protein and Leucine Supplementation to Induce Anabolism in COPD Patients and Healthy Elderly.
Hydrolyzed casein protein; Hydrolyzed casein protein + carbohydrates; Hydrolyzed casein protein + leucine; Hydrolyzed casein protein + carbohydrates + leucine

COPD, or Healthy Subjects Clinical Trial using AZD7624; Placebo to match

AstraZeneca - Recruiting 18 years to 55 years.
- A Phase I, Randomized, DoubleBlind Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Inhaled Doses (MAD) of AZD7624 to Healthy Subjects and Patients With COPD.
AZD7624; Placebo to match

COPD Clinical Trial using ASM-024; Placebo

Asmacure Lt‚e - Recruiting 40 years or older.
- A Randomized, Double-blind, Placebo-controlled, Two-Way Crossover Study to Evaluate the Safety, Tolerability and Clinical Activity of ASM-024 Administered by Dry Power Inhalation to Patients With GOLD 2 (Moderate) or GOLD 3 (Severe) Chronic Obstructive Pulmonary Disease (COPD).
ASM-024; Placebo

Chronic Obstructive Pulmonary Disease Clinical Trial using Home mechanical ventilation

Fundaci¢ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau - Recruiting N/A to 80 years.
- Home Mechanical Ventilation in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Develop Nocturnal Hypercapnic Response Associated to Oxygen Therapy.
Home mechanical ventilation

Asthma, or COPD Clinical Trial

Medical University of Warsaw - Recruiting 18 years to 90 years.
- Relationship Between Airway Inflammation and Remodeling in Asthma and COPD Patients..

Advanced COPD (GOLD Stage 3 or 4) With Cachexia Clinical Trial using Serum bovine immunoglobulin (SBI) medical food; Placebo (for serum bovine immunoglobulin)

Medical University of South Carolina - Recruiting 30 years to 80 years.
- A Randomized, Double Blinded, Placebo-controlled Pilot Study of Serum Bovine Immunoglobulin (SBI) for Cachexia in Patients With Advanced COPD.
Serum bovine immunoglobulin (SBI) medical food; Placebo (for serum bovine immunoglobulin)

Chronic Obstructive Pulmonary Disease, or COPD Exacerbation Clinical Trial

Cantonal Hosptal, Baselland - Recruiting 40 years or older.
- Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort COPD-Management: Eine Klinisch-epidemiologische Verlaufsbeobachtung in Hausarztpraxen.

Pulmonary Disease, Chronic Obstructive Clinical Trial using fluticasone propionate/salmeterol 50/250mcg; fluticasone propionate/salmeterol placebo; tiotropium bromide 18mcg; tiotropium bromide placebo; fluticasone propionate/salmeterol 50/250mcg and tiotropium 18mcg

GlaxoSmithKline - Recruiting 40 years to 80 years.
- Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg.
fluticasone propionate/salmeterol 50/250mcg; fluticasone propionate/salmeterol placebo; tiotropium bromide 18mcg; tiotropium bromide placebo; fluticasone propionate/salmeterol 50/250mcg and tiotropium 18mcg

Pulmonary Disease, Chronic Obstructive Clinical Trial using Spirometry

GlaxoSmithKline - Recruiting 40 years or older.
- Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care.
Spirometry

Pulmonary Disease, Chronic Obstructive Clinical Trial using FF/VI; Existing Maintenance Therapy

GlaxoSmithKline - Recruiting 40 years or older.
- A 12-month, Open Label, Randomised, Effectiveness Study to Evaluate Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) Inhalation Powder Delivered Once Daily Via a Novel Dry Powder Inhaler (NDPI) Compared With the Existing COPD Maintenance Therapy Alone in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
FF/VI; Existing Maintenance Therapy

Pulmonary Disease, Chronic Obstructive Clinical Trial using fluticasone furoate/vilanterol; fluticasone furoate; vilanterol; Placebo

GlaxoSmithKline - Recruiting 40 years to 80 years.
- A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease.
fluticasone furoate/vilanterol; fluticasone furoate; vilanterol; Placebo

Chronic Obstructive Pulmonary Disease Clinical Trial using Quercetin

University of Michigan - Recruiting 40 years to 80 years.
- Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD Patients.
Quercetin

Pulmonary Hypertension, or Chronic Obstructive Pulmonary Disease Clinical Trial using Inhaled NO; Placebo

INO Therapeutics - Recruiting 40 years to 80 years.
- A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1.
Inhaled NO; Placebo

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial using AZD4721; Placebo; AZD5069

AstraZeneca - Recruiting 18 years to 50 years.
- A Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4721 After Once Daily Administration of Multiple Ascending Doses for 10 Days, and an Open-label Comparison With the Pharmacodynamics of AZD5069 Given Twice Daily for 3 Days.
AZD4721; Placebo; AZD5069

Pulmonary Disease, Chronic Obstructive Clinical Trial using Fatiguing exercise

Laval University - Recruiting 50 years to 75 years.
- Muscle Oxygenation and Metabolism in Response to a Localized Fatigue-inducing Exercise in Patients With Chronic Obstructive Pulmonary Disease.
Fatiguing exercise

Mature B-Cell Lymphoma Clinical Trial using COPAD; COP, COPD M3, CYM; COP, COPADM8, CYVE

St. Jude Children's Research Hospital - Recruiting N/A to 21 years.
- Mature B-Cell Lymphoma And Leukemia Study III.
COPAD; COP, COPD M3, CYM; COP, COPADM8, CYVE

Pulmonary Disease, Chronic Obstructive Clinical Trial using Self-Management and Motivational Interviewing

Mayo Clinic - Recruiting 40 years or older.
- Multicomponent Intervention to Decrease COPD-related Hospitalizations.
Self-Management and Motivational Interviewing

HIV, COPD, Emphysema, or Smoking Clinical Trial using Genetic: Examination of the interaction of HIV directly on the small airway epithelium

Weill Medical College of Cornell University - Recruiting 18 years or older.
- HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium.
Genetic: Examination of the interaction of HIV directly on the small airway epithelium

HIV, COPD, Chronic Obstructive Pulmonary Disease, or Smoking Clinical Trial using Examination of the interaction of HIV directly on the small airway epithelium

Weill Medical College of Cornell University - Recruiting 18 years or older.
- HIV-related Accelerated Aging of the Airway Epithelium.
Examination of the interaction of HIV directly on the small airway epithelium

COPD, Exercise, or Resistance Training Clinical Trial using Resistance training; Endurance training

Rigshospitalet, Denmark - Recruiting 40 years to 80 years.
- The Effects of Physical Exercise Training on in Patients With Chronic Obstructive Pulmonary Disease.
Resistance training; Endurance training

Pulmonary Disease, Chronic Obstructive Clinical Trial using Telemedicine

Aalborg University - Recruiting N/A or older.
- Effectiveness and Cost-effectiveness of Telemedicine for Chronic Obstructive Pulmonary Disease: The Danish 'TeleCare North' Pragmatic Cluster-randomized Trial..
Telemedicine

Pulmonary Disease, Chronic Obstructive Clinical Trial using Fluticasone Furoate/Vilanterol; Vilanterol; Placebo

GlaxoSmithKline - Recruiting 40 years or older.
- A 24-week Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol 100/25 Mcg Inhalation Powder Delivered Once-daily Via a Novel Dry Powder Inhaler on Arterial Stiffness Compared With Placebo and Vilanterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)..
Fluticasone Furoate/Vilanterol; Vilanterol; Placebo

Pulmonary Disease, Chronic Obstructive Clinical Trial using tiotropium bromide; Placebo

Boehringer Ingelheim Pharmaceuticals - Recruiting 40 years or older.
- A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 æg) Delivered Via the HandiHalerr in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 1).
tiotropium bromide; Placebo

Pulmonary Disease, Chronic Obstructive Clinical Trial using self-monitoring for patients with severe COPD; nurse-monitoring for patients with severe COPD

Regione Veneto - Recruiting 18 years or older.
- RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring in COPD.
self-monitoring for patients with severe COPD; nurse-monitoring for patients with severe COPD

Chronic Obstructive Pulmonary Disease Clinical Trial

AstraZeneca - Recruiting N/A or older.
- Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for COPD Patients.

Peripheral Muscle Dysfunction, or COPD Clinical Trial using Muscular biopsy; 5-10 weeks sport training

University Hospital, Montpellier - Recruiting 40 years to 78 years.
- Impact of Different Training Modalities on Skeletal Muscle Angiogenic Response in COPD Patients - COPDævasc Study.
Muscular biopsy; 5-10 weeks sport training

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial using QVA149; Tiotropium; placebo

Novartis - Recruiting 40 years or older.
- A Placebo and Active Controlled Study to Assess the Long-term Safety of Once Daily QVA149 for 52 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate to Severe Airflow Limitation.
QVA149; Tiotropium; placebo

Emphysema Clinical Trial using RePneu Lung Volume Reduction Coil System

PneumRx, Inc. - Recruiting 35 years or older.
- Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study.
RePneu Lung Volume Reduction Coil System

Chronic Obstructive Pulmonary Disease, or Patients Hospitalized f Clinical Trial using PEP

University Hospital, Brest - Recruiting 18 years or older.
- Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD).
PEP

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial using NVA237; Long-acting beta 2-agonist (LABA); Placebo

Novartis - Recruiting 40 years or older.
- A Multi-center, Randomized, Double-blind, 52-week Study to Assess the Safety of NVA237 Compared to QAB149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Have Moderate to Severe Airflow Limitation.
NVA237; Long-acting beta 2-agonist (LABA); Placebo

Diabetes Mellitus (DM), Congestive Heart Failure (CHF), or Chroni Clinical Trial using Community Paramedicine; Usual Care

St. Michael's Hospital, Toronto - Recruiting 18 years or older.
- The Expanding Paramedicine in the Community (Study).
Community Paramedicine; Usual Care

Pulmonary Disease, Chronic Obstructive Clinical Trial using tiotropium bromide; Placebo

Boehringer Ingelheim Pharmaceuticals - Recruiting 40 years or older.
- A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 æg) Delivered Via the HandiHalerr in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 2).
tiotropium bromide; Placebo

Remote Patient Monitoring in COPD Patients Clinical Trial using Remote Patient Monitoring; Usual care

Novartis - Recruiting 40 years or older.
- A 52-week Multi-center Randomized Trial to Evaluate Remote Patient Monitoring Using the EXACT Patient-reported Outcome Tool on Reduction of Hospitalizations From Exacerbations in Patients With Chronic Obstructive Pulmonary Disease as Compared to Those Managed by Usual Care.
Remote Patient Monitoring; Usual care

Pulmonary Disease, Chronic Obstructive Clinical Trial using Aclidinium Bromide / Formoterol Fumarate; Salmeterol / Fluticasone

Almirall, S.A. - Recruiting 40 years or older.
- A Randomised, Double-blind, Double-dummy, Active-controlled Study Evaluating the Efficacy, Safety and Tolerability of Twice-daily Aclidinium Bromide/Formoterol Fumarate Compared With Twice-daily Salmeterol/Fluticasone Propionate for 24 Weeks Treatment in Symptomatic Patients With Chronic Obstructive Pulmonary Disease (COPD).
Aclidinium Bromide / Formoterol Fumarate; Salmeterol / Fluticasone

COPD Clinical Trial using Peforomist-Placebo; Perforomist, nebulization, COPD

Dey - Recruiting 40 years or older.
- A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of Long-Term Use of Perforomistr (Formoterol Fumarate) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Peforomist-Placebo; Perforomist, nebulization, COPD

Pulmonary Disease, Chronic Obstructive Clinical Trial using Fluticasone Furoate; Vilanterol

GlaxoSmithKline - Recruiting 40 years or older.
- A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults With Chronic Obstructive Pulmonary Disease (COPD).
Fluticasone Furoate; Vilanterol

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial using Implementation educational programme

Medical Universtity of Lodz - Recruiting 18 years or older.
- Tailored Implementation for Chronic Diseases..
Implementation educational programme

Chronic Obstructive Pulmonary Disease Clinical Trial using niv plus oxygen therapy; oxygen therapy

Guangzhou Institute of Respiratory Disease - Recruiting 30 years to 80 years.
- The Efficacy of Non-invasive Mechanical Ventilation as a Rescue Therapy for Relieving Dyspnea in Patients With Stable Severe COPD.
niv plus oxygen therapy; oxygen therapy

Cancer, Congestive Heart Failure (CHF), Chronic Obstructive Pulmo Clinical Trial using Life Completion; Attention Control

Department of Veterans Affairs - Recruiting 18 years or older.
- Outlook: An Intervention to Improve Quality of Life in Serious Illness Study.
Life Completion; Attention Control

Chronic Obstructive Pulmonary Disease Clinical Trial using NVA237; Tiotropium; Placebo to NVA237; Placebo to tiotropium; Salbutamol

Novartis - Recruiting 40 years or older.
- A Randomized, Double-blind, Multicenter, 2-period Single-dose Cross-over Study to Assess the Early Bronchodilation of Glycopyrronium Bromide (44 æg o.d.) Compared to Tiotropium (18 æg. o.d.) in Patients With Moderate to Severe COPD (FAST Study).
NVA237; Tiotropium; Placebo to NVA237; Placebo to tiotropium; Salbutamol

COPD, or Muscle Weakness Clinical Trial using Resistance training in AECOPD

Frederikssunds Hospital, Denmark - Recruiting N/A or older.
- Feasibility of Progressive Knee Extension Strength Training Using Ankle Weight Cuffs in Patients Hospitalized With COPD in Acute Exacerbation.
Resistance training in AECOPD

Chronic Obstructive Pulmonary Disease, COPD, or Chronic Bronchiti Clinical Trial using Inhaled HS home treatment

University of North Carolina, Chapel Hill - Recruiting 40 years to 80 years.
- Novel Therapies for Muco-Obstructive Lung Diseases: Sustained Effects of Hypertonic Saline on Mucociliary Clearance and Clinical Tolerability in Subjects With Chronic Bronchitis.
Inhaled HS home treatment

Obesity, Diabetes, Hypertension, or Asthma/COPD With Tobacco Depe Clinical Trial using CHW Goal Support

University of Pennsylvania - Recruiting N/A or older.
- Community Health Worker Support to Help Patients Control Chronic Disease.
CHW Goal Support

COPD Clinical Trial using bambuterol; Placebo

The First Affiliated Hospital of Guangzhou Medical University - Recruiting 40 years to 80 years.
- A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD).
bambuterol; Placebo

High Blood Pressure Clinical Trial using Placebo; Nebivolol

University of Chicago - Recruiting 40 years to 75 years.
- Nebivolol in Chronic Obstructive Pulmonary Disease.
Placebo; Nebivolol

Emphysema Clinical Trial using Endoscopic lung volume reduction

Assaf-Harofeh Medical Center - Recruiting 40 years to 75 years.
- Lung Volume Reduction in COPD Patients With an Inhomogeneous Severe Emphysema Located in the Upper Lobes, by Injecting Warm Saline Through the Bronchoscope Channel.
Endoscopic lung volume reduction

Lung Transplantation, or Chronic Obstructive Pulmonary Disease Clinical Trial

Katholieke Universiteit Leuven - Recruiting 18 years to 80 years.
- Confocal Laser Micro-endoscopy: New Insights in COPD and Lung Transplant Recipients.

Chronic Obstructive Pulmonary Disease Clinical Trial

Katholieke Universiteit Leuven - Recruiting 40 years or older.
- Adherence to Medication and Its Impact on COPD Exacerbations: The AMICE Prospective Study.

Pulmonary Disease, Chronic Obstructive, or Lung Diseases, Obstruc Clinical Trial using Blood drawing; Bronchoalveolar lavage during indicated bronchoscopy

University of Michigan - Recruiting 40 years or older.
- Innate and Adaptive Immunity in COPD Exacerbations: Clinically-Indicated Bronchoscopies.
Blood drawing; Bronchoalveolar lavage during indicated bronchoscopy

Chronic Obstructive Pulmonary Disease, or Type 2 Diabetes Clinical Trial using Tool; Self-management Support Program

Maastricht University Medical Center - Recruiting 40 years to 70 years.
- RCT It's LiFe! to Evaluate the Effectiveness of the Monitoring and Feedback Tool and the Corresponding Counseling Protocol (Self-management Support Program) to be Executed by Practice Nurses in Primary Care.
Tool; Self-management Support Program

COPD Clinical Trial using Lifestyle physical activity - self-efficacy

University of Michigan - Recruiting 55 years or older.
- Lifestyle Physical Activity for People With COPD.
Lifestyle physical activity - self-efficacy

COPD Clinical Trial using Oxygen; Medical air equivalent

University of Birmingham - Recruiting 18 years or older.
- Can Muscle Dysfunction in COPD be Altered by Oxygenation in Patients With Intermittent Hypoxia on Exertion?.
Oxygen; Medical air equivalent

COPD Clinical Trial using Sulforaphane 25; Sulforaphane 150; Placebo

Johns Hopkins University - Recruiting 40 years or older.
- Enhancing Nrf2 by Sulforaphane Treatment in COPD.
Sulforaphane 25; Sulforaphane 150; Placebo

Asthma, COPD, or Healthy Clinical Trial using HXe MRI lung ventilation

Xemed LLC - Recruiting 21 years to 75 years.
- Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation.
HXe MRI lung ventilation

Coronary Artery Disease, Cerebral Vascular Disease, Peripheral Ar Clinical Trial

New York University School of Medicine - Recruiting 21 years or older.
- Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients.

COPD Clinical Trial using Transcutaneous Electrical Muscle Stimulation (TCEMS)

Yale University - Recruiting N/A to 75 years.
- Rehabilitation of Patients With COPD Using Electrical Muscle Stimulation.
Transcutaneous Electrical Muscle Stimulation (TCEMS)

COPD Clinical Trial using Lysozyme hydrochloride; Placebo

Eisai Inc. - Recruiting 20 years to 84 years.
- Effects of Lysozyme On Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study.
Lysozyme hydrochloride; Placebo

Chronic Obstructive Pulmonary Disease Clinical Trial

Columbia University - Recruiting 50 years to 75 years.
- Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary (MESA-COPD).

CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, or HEALTHY SUBJECT Clinical Trial using SALBUTAMOL

Imperial College London - Recruiting 18 years or older.
- Improving Inhaler Treatment and Small Airways Assessment in Chronic Obstructive Pulmonary Disease (COPD).
SALBUTAMOL

COPD Clinical Trial using Exercise training

Universidade Norte do Paraná - Recruiting 50 years or older.
- Effects of Two Training Protocols in Physical Activity in Daily Life and Balance in Patients With COPD: Land Versus Water.
Exercise training

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial

Cardiff University - Recruiting 35 years to 80 years.
- Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE).

Chronic Obstructive Pulmonary Disease and Allied Conditions Clinical Trial using Roflumilast; Placebo

LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology - Recruiting 40 years to 80 years.
- Effects of ROFLUMILAST on Markers of Subclinical Atherosclerosis In Stable COPD; the ELASTIC-trial.
Roflumilast; Placebo

Chronic Obstructive Pulmonary Disease Clinical Trial using AVAPS-AE; AVAPS-AE mode of ventilator therapy

Philips Respironics - Recruiting 18 years or older.
- Engineering Validation of the AVAPS-AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD)Patients.
AVAPS-AE; AVAPS-AE mode of ventilator therapy

Chronic Obstructive Pulmonary Disease Clinical Trial using theophylline; placebo

Hospital Son Espases - Recruiting 45 years to 90 years.
- Multicenter 52 Weeks Double Blind Placebo-controlled Trial for the Assessment of Theophylline on Top of Combination Therapy in Severe COPD.
theophylline; placebo

COPD Patients, Healthy Subjects, Semi-supine Echo (SSE), Flow-med Clinical Trial using Measure pulmonary artery pressure change during exercise; Pulmonary pressure response during exercise

Szeged University - Recruiting 45 years to 70 years.
- Pulmonary Arterial Pressure Response During Exercise in COPD and Healthy Subjects.
Measure pulmonary artery pressure change during exercise; Pulmonary pressure response during exercise

Obesity, or Chronic Obstructive Pulmonary Disease Clinical Trial using Ventilator setting changes

Bridgeport Hospital - Recruiting 18 years or older.
- What Ventilator Settings Are Most Comfortable for Patients With COPD or Obesity..
Ventilator setting changes

Sleep-disordered Breathing, or Chronic Heart Failure Clinical Trial

LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology - Recruiting 18 years to 80 years.
- Prevalence, Incidence and Clinical Characteristics of Sleep Disordered Breathing in Patients With Stable Chronic Heart Failure.

Emphysema, or Chronic Obstructive Pulmonary Disease Clinical Trial using Bronchoscopic Lung Volume Reduction (BLVR)

LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology - Recruiting 40 years to 75 years.
- A Multi-Center, Prospective, Clinical Trial Designed to Study the Efficacy of One-Way Valve Implantation Based on a New Treatment Algorithm in Patients With Heterogeneous Emphysema.
Bronchoscopic Lung Volume Reduction (BLVR)

Chronic Obstructive Pulmonary Disease Clinical Trial

Imperial College London - Recruiting 38 years to 80 years.
- The Effect of Inhaled Mannitol on Ciliary Beat Frequency in COPD Patients.

Chronic Obstructive Airway Disease, or Healthy Volunteers Clinical Trial using Up to 100ml blood will be taken by venupuncture.

Imperial College London - Recruiting 21 years to 75 years.
- Regulation of the Release of Inflammatory Mediators From Blood Leukocytes: A Comparison of Healthy Subjects, Healthy Smokers and Patients With COPD..
Up to 100ml blood will be taken by venupuncture.

Asthma, COPD, or Cough Clinical Trial

National Taiwan University Hospital - Recruiting 18 years or older.
- Association Between Sputum and Plasma Levels of Nociceptin and Substance P With Cough Severity and Airway Hyperreactivity in Patients With Asthma, COPD and Chronic Cough.